Google
CDXS — CODEXIS INC (Healthcare >> Biotechnology)
CDXS FAQ
What is CDXS's P/E ratio?
CODEXIS INC (CDXS) currently trades at a P/E ratio of 26.51.
What is CDXS's ROE?
CODEXIS INC reports a Return on Equity (ROE) of -73.99%.
What is CDXS's dividend yield?
CODEXIS INC offers a dividend yield of 0.00%.
What is CDXS's Deepscope Quality Score?
Deepscope rates CDXS's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CDXS?
Deepscope's AI Timing Score for CDXS is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CDXS belong to?
CODEXIS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.56
Price
-0.24
(-8.57%)
Day Change
|
|
|---|
CDXS, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.56 |
| PBV / Sector |
5.89 / 4.63
|
| Earning Per Share | -0.32 |
| PE / Sector |
26.51 / 17.43
|
| PEG or PE/Growth / Sector |
1.48 / 0.53
|
| Average 1M Daily Value |
2.26 M
GREAT
|
| Average 1W Daily Value |
2.20 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
43% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:29 |
| Symbol | CDXS |
| Name | CODEXIS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 90.90 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 254.51 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063
Phone: 650 421 8100
Website: https://www.codexis.com
Employees: 146
Sector: Healthcare >> Biotechnology
Description: Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
